It enabled us to show that NGF not only elicits the insulin pathway and controls glucose metabolism by Glut2 translocation to the plasmamembrane in healthy BFCN, but it also reduces BFCN insulin resistance by re-activating the IRS1-driven insulin pathway in vitro and in AD mice. The gene discussed is INS; the disease is Alzheimer disease.